Skip to content
Search

Latest Stories

Haleon appoints Jo Cooper as new GM for UK and Ireland

Haleon’s new GM for UK and Ireland announced
Jo Cooper, General Manager UK&I, Haleon,

Previously, Cooper served as head of commercial excellence for EMEA&LATAM regions at Haleon for over three years

Haleon, a leading consumer healthcare company, has appointed Jo Cooper as the new general manager for the UK and Ireland, effective 1st January 2025.

With a decade of experience in senior leadership roles within the consumer healthcare sector, Cooper has a strong track record in accelerating business growth across several international markets.


Prior to this appointment, she served as head of commercial excellence for Europe, Middle East and Africa, and Latin America (EMEA&LATAM) regions at Haleon for over three years.

In that role, she was responsible for revenue growth strategy, category management, shopper marketing, and retail partner leadership across Haleon’s multi-brand portfolio.

She also led the global net revenue management acceleration programme, working closely with digital and tech teams.

Cooper’s career began with GlaxoSmithKline Consumer Healthcare (GSK), where she joined as pharmacy and field director in 2013.

She went on to hold several positions, including grocery and digital commerce sales director and commercial excellence director, before joining Haleon in 2021 following the company’s de-merger.

Expressing her enthusiasm for the new role, Cooper said: “I am thrilled to take on the role of leading Haleon’s UK and Ireland business, my home market.

“Having experienced first-hand the exceptional talent and dedication within the UK and Ireland team and Northern Europe business unit, I am eager to collaborate and drive the next level of growth together, continuing to develop our vision for delivering consumer-first healthcare.

“I’m proud to be part of Haleon and am looking forward to this exciting new chapter.”

Jon Workman, general manager Northern Europe, Haleon, commended Cooper’s outstanding experience and incredible track record in strong leadership positions.

“After playing such a critical role in delivering the EMEA&LATAM commercial agenda over the last three years, her experience, relationship with retail partners and growth mindset is perfectly placed to continue to drive the momentum of the UK and Ireland business into the next phase,” he said.

 

More For You

 RPS honours Professor Tony Avery OBE for excellence in prescribing safety and patient care

Professor Tony Avery OBE

Pic credit: RPS

Professor Tony Avery OBE awarded RPS Honorary Fellowship

The Royal Pharmaceutical Society (RPS) Assembly has awarded an Honorary Fellowship to Professor Tony Avery OBE in recognition of his outstanding contribution to prescribing safety and patient care.

The Honorary Fellowship is given to those who are not eligible for membership of the Society but have either attained a distinction in a particular aspect or aspects of pharmacy, made a distinctive contribution to pharmacy or the RPS, distinguished themselves in any branches of knowledge referred to in the objects of the Society or achieved eminence in public life.

Keep ReadingShow less
US-UK pharmaceutical trade concerns as Liberal Democrat MPs urge protection from Trump tariffs.

UK prime minster Sir Keir Starmer with US president Donald Trump

Pic credit: Getty images

Pharma sector needs protecting from Trump tariffs, warn MPs

A group of Liberal Democrat MPs have written to health secretary Wes Streeting urging him to protect the pharmaceutical industry from US president Donald Trump’s trade war.

The five ministers from Oxfordshire, Olly Glover, Layla Moran, Calum Miller, Charlie Maynard, and Freddie van Mierlo, have warned that Trump’s campaign to raise tariffs has already led to “catastrophic damage”.

Keep ReadingShow less
Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less